139 related articles for article (PubMed ID: 18987104)
1. Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
Lomer NB; Asalemi KA; Saberi A; Sarlak K
PLoS One; 2024; 19(4):e0300415. PubMed ID: 38626023
[TBL] [Abstract][Full Text] [Related]
2. Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
Akaishi T; Takahashi T; Fujihara K; Misu T; Mugikura S; Abe M; Ishii T; Aoki M; Nakashima I
PLoS One; 2020; 15(4):e0231225. PubMed ID: 32243459
[TBL] [Abstract][Full Text] [Related]
3. Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.
Arnold DL; Gold R; Kappos L; Bar-Or A; Giovannoni G; Selmaj K; Yang M; Zhang R; Stephan M; Sheikh SI; Dawson KT
J Neurol; 2014 Sep; 261(9):1794-802. PubMed ID: 24989666
[TBL] [Abstract][Full Text] [Related]
4. Relapsing and progressive forms of multiple sclerosis: insights from pathology.
Dutta R; Trapp BD
Curr Opin Neurol; 2014 Jun; 27(3):271-8. PubMed ID: 24722325
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.
Naismith RT; Bermel RA; Coffey CS; Goodman AD; Fedler J; Kearney M; Klawiter EC; Nakamura K; Narayanan S; Goebel C; Yankey J; Klingner E; Fox RJ;
Neurology; 2021 Jan; 96(4):e491-e500. PubMed ID: 33268562
[TBL] [Abstract][Full Text] [Related]
6. Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models.
Chua AS; Egorova S; Anderson MC; Polgar-Turcsanyi M; Chitnis T; Weiner HL; Guttmann CR; Bakshi R; Healy BC
Neuroimage Clin; 2015; 8():606-10. PubMed ID: 26199872
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of MS phenotypes across the age span using a novel data set integrating 34 clinical trials (NO.MS cohort): Age is a key contributor to presentation.
Dahlke F; Arnold DL; Aarden P; Ganjgahi H; Häring DA; Čuklina J; Nichols TE; Gardiner S; Bermel R; Wiendl H
Mult Scler; 2021 Nov; 27(13):2062-2076. PubMed ID: 33507835
[TBL] [Abstract][Full Text] [Related]
8. Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for the routinely used magnetic resonance imaging protocol in patients with multiple sclerosis.
Sąsiadek M; Hartel M; Siger M; Katulska K; Majos A; Kluczewska E; Bartosik-Psujek H; Kułakowska A; Słowik A; Steinborn B; Adamczyk-Sowa M; Kalinowska A; Krzystanek E; Bonek R; Serafin Z; Sławek J; Nowacki P; Stępień A; Jóżwiak S; Rejdak K; Selmaj K; Walecki J
Pol J Radiol; 2020; 85():e272-e276. PubMed ID: 32612727
[TBL] [Abstract][Full Text] [Related]
9. Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning.
van den Dorpel JJA; Mackenbach MJ; Dremmen MHG; van der Vlugt WMC; Rizopoulos D; van Doorn PA; van der Ploeg AT; Muetzel R; van der Beek NAME; van den Hout JMP
J Inherit Metab Dis; 2024 Apr; ():. PubMed ID: 38584574
[TBL] [Abstract][Full Text] [Related]
10. Magnetic Resonance Imaging in Multiple Sclerosis.
Hemond CC; Bakshi R
Cold Spring Harb Perspect Med; 2018 May; 8(5):. PubMed ID: 29358319
[TBL] [Abstract][Full Text] [Related]
11. The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.
Rocca MA; Comi G; Filippi M
Front Neurol; 2017; 8():433. PubMed ID: 28928705
[TBL] [Abstract][Full Text] [Related]
12. Depressive symptoms in multiple sclerosis from an in vivo study with TBSS.
Shen Y; Bai L; Gao Y; Cui F; Tan Z; Tao Y; Sun C; Zhou L
Biomed Res Int; 2014; 2014():148465. PubMed ID: 24877057
[TBL] [Abstract][Full Text] [Related]
13. Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years.
Zivadinov R; Bergsland N; Dolezal O; Hussein S; Seidl Z; Dwyer MG; Vaneckova M; Krasensky J; Potts JA; Kalincik T; Havrdová E; Horáková D
AJNR Am J Neuroradiol; 2013 Oct; 34(10):1931-9. PubMed ID: 23578679
[TBL] [Abstract][Full Text] [Related]
14. BDNF Val66Met polymorphism and brain volumes in multiple sclerosis.
Dinacci D; Tessitore A; Russo A; De Bonis ML; Lavorgna L; Picconi O; Sacco R; Bonavita S; Gallo A; Servillo G; Marcuccio L; Comerci M; Galletti P; Alfano B; Tedeschi G
Neurol Sci; 2011 Feb; 32(1):117-23. PubMed ID: 20953813
[TBL] [Abstract][Full Text] [Related]
15. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
17. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
18. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
[TBL] [Abstract][Full Text] [Related]
19. MRI relapses have significant pathologic and clinical implications in multiple sclerosis.
Traboulsee A
J Neurol Sci; 2007 May; 256 Suppl 1():S19-22. PubMed ID: 17346748
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
